Antitumor effect of mitoxantrone-containing liposomes

International Journal of Pharmaceutics

Volumn 128, Issue 1-2, 1996, Pages 139-143

  Law, S L ^a   Ho, C K ^a   Jang, T F ^a   Chang, P ^b   Lin, F M ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

antitumor effect; CDF1 mouse; L1210 cell; liposome; mitoxantrone

Indexed keywords

LIPOSOME; MITOXANTRONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; ENCAPSULATION; FEMALE; LEUKEMIA; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030007332     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04250-4     Document Type: Article

References (9)

1. Batra, V.K., Morrison, J.A., Woodward, D.L., Siverd, N.S. and Yacobi, A., Pharmacokinetics of mitoxantrone in man and laboratory animals. Drug Metab. Rev., 17 (1986) 311-329.
2. Gabizon, A., Goren, D., Fuks, Z., Barenholz, Y, Dagan, A. and Meshorer, A., Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers. Cancer Res., 43 (1983) 4730-4735.
3. Gregoriadis, G., Swain, C.P., Wills, E.J. and Tavill, A.S., Drug-carrier potential of liposomes in cancer chemotherapy. Lancet, (1974) 1313-1316.
4. Law, S.L., Chang, P. and Lin, C.H., Characteristics of mitoxantrone loading on liposomes. Int. J. Pharm., 70 (1991) 1-7.
5. Law, S.L., Jang, T.F., Chang, P. and Lin, C.H., Release characteristics of mitoxantrone-containing liposomes. Int. J. Pharm., 103 (1994) 81-85.
6. Law, S.L., Jang, T.F., Chang, P. and Lin, F.M., Stability of mitoxantrone-containing liposomes. Int. J. Pharm., 116 (1995) 87-93.
7. Patel, K.R., Jonah, M.M. and Rahman, Y.E., In vitro uptake and therapeutic application of liposome-encapsulated methotrexate in mouse hepatoma 129. Eur. J. Cancer Clin. Oncol., 18 (1982) 833-843.
8. Schwendener, R.A., Fiebig, H.H., Berger, M.R. and Berger, D.P., Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy. Cancer Chemother. Pharmacol., 27 (1991) 429-439.
9. Wallace, R.E., Murdock, K.C., Angier, R.B. and Durr, F.E., Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis {{{2-[(2-hydroxyethyl)amino]ethyl}amino}}-9,10-anthracenedione dihydrochloride, against experi-mental tumors in mice. Cancer Res., 39 (1979) 1570-1574.